Medical Second Opinion Industry Research Report 2024

February 2024 | 98 pages | ID: ME899027446FEN
APO Research

Abstracts

This report aims to provide a comprehensive presentation of the global market for Medical Second Opinion, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Second Opinion.

The Medical Second Opinion market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Medical Second Opinion market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Medical Second Opinion companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

• HCA Hospitals
• AXA PPP Healthcare
• Royal London Group
• Helsana Group
• Cleveland Clinic
• Amradnet
• Best Doctors Inc
• Inova Care
• Toranomon Hospital
• Keio University Hospital
• Johns Hopkins Medicine
• Penn Medicine
• Oncology International Pvt. Ltd.
• GrandOpinion
• London Pain Clinic
• Mondial Assistance
• Medisense
• Medo Asia Sdn. Bhd.

Product Type Insights

Global markets are presented by Medical Second Opinion type, along with growth forecasts through 2030. Estimates on revenue are based on the price in the supply chain at which the Medical Second Opinion are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2019-2024) and forecast period (2025-2030).

Medical Second Opinion segment by Type

• Hospitals
• Medical Second Opinion Providing Companies
• Health Insurance Companies

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2019-2024) and forecast period (2025-2030).

This report also outlines the market trends of each segment and consumer behaviors impacting the Medical Second Opinion market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Medical Second Opinion market.

Medical Second Opinion Segment by Application

• Cancer
• Diabetes
• Cardiac Disorders
• Neurological Disorders
• Ocular Disorders
• Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2019-2030.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2023 because of the base year, with estimates for 2024 and forecast revenue for 2030.

• North America
• United States
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Nordic Countries
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia
• Latin America
• Mexico
• Brazil
• Rest of Latin America
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Medical Second Opinion market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Second Opinion market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Medical Second Opinion and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Medical Second Opinion industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Second Opinion.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Medical Second Opinion companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

Contents

1 PREFACE

1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
  1.5.1 Secondary Sources
  1.5.2 Primary Sources

2 MARKET OVERVIEW

2.1 Product Definition
2.2 Medical Second Opinion by Type
  2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
  1.2.2 Hospitals
  1.2.3 Medical Second Opinion Providing Companies
  1.2.4 Health Insurance Companies
2.3 Medical Second Opinion by Application
  2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
  2.3.2 Cancer
  2.3.3 Diabetes
  2.3.4 Cardiac Disorders
  2.3.5 Neurological Disorders
  2.3.6 Ocular Disorders
  2.3.7 Others
2.4 Assumptions and Limitations

3 MEDICAL SECOND OPINION BREAKDOWN DATA BY TYPE

3.1 Global Medical Second Opinion Historic Market Size by Type (2019-2024)
3.2 Global Medical Second Opinion Forecasted Market Size by Type (2025-2030)

4 MEDICAL SECOND OPINION BREAKDOWN DATA BY APPLICATION

4.1 Global Medical Second Opinion Historic Market Size by Application (2019-2024)
4.2 Global Medical Second Opinion Forecasted Market Size by Application (2019-2024)

5 GLOBAL GROWTH TRENDS

5.1 Global Medical Second Opinion Market Perspective (2019-2030)
5.2 Global Medical Second Opinion Growth Trends by Region
  5.2.1 Global Medical Second Opinion Market Size by Region: 2019 VS 2023 VS 2030
  5.2.2 Medical Second Opinion Historic Market Size by Region (2019-2024)
  5.2.3 Medical Second Opinion Forecasted Market Size by Region (2025-2030)
5.3 Medical Second Opinion Market Dynamics
  5.3.1 Medical Second Opinion Industry Trends
  5.3.2 Medical Second Opinion Market Drivers
  5.3.3 Medical Second Opinion Market Challenges
  5.3.4 Medical Second Opinion Market Restraints

6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS

6.1 Global Top Medical Second Opinion Players by Revenue
  6.1.1 Global Top Medical Second Opinion Players by Revenue (2019-2024)
  6.1.2 Global Medical Second Opinion Revenue Market Share by Players (2019-2024)
6.2 Global Medical Second Opinion Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Medical Second Opinion Head office and Area Served
6.4 Global Medical Second Opinion Players, Product Type & Application
6.5 Global Medical Second Opinion Players, Date of Enter into This Industry
6.6 Global Medical Second Opinion Market CR5 and HHI
6.7 Global Players Mergers & Acquisition

7 NORTH AMERICA

7.1 North America Medical Second Opinion Market Size (2019-2030)
7.2 North America Medical Second Opinion Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Medical Second Opinion Market Size by Country (2019-2024)
7.4 North America Medical Second Opinion Market Size by Country (2025-2030)
7.5 United States
7.6 Canada

8 EUROPE

8.1 Europe Medical Second Opinion Market Size (2019-2030)
8.2 Europe Medical Second Opinion Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Medical Second Opinion Market Size by Country (2019-2024)
8.4 Europe Medical Second Opinion Market Size by Country (2025-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries

9 ASIA-PACIFIC

9.1 Asia-Pacific Medical Second Opinion Market Size (2019-2030)
9.2 Asia-Pacific Medical Second Opinion Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Medical Second Opinion Market Size by Country (2019-2024)
9.4 Asia-Pacific Medical Second Opinion Market Size by Country (2025-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia

10 LATIN AMERICA

10.1 Latin America Medical Second Opinion Market Size (2019-2030)
10.2 Latin America Medical Second Opinion Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Medical Second Opinion Market Size by Country (2019-2024)
10.4 Latin America Medical Second Opinion Market Size by Country (2025-2030)
9.4 Mexico
9.5 Brazil

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Medical Second Opinion Market Size (2019-2030)
11.2 Middle East & Africa Medical Second Opinion Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Medical Second Opinion Market Size by Country (2019-2024)
11.4 Middle East & Africa Medical Second Opinion Market Size by Country (2025-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE

12 PLAYERS PROFILED

11.1 HCA Hospitals
  11.1.1 HCA Hospitals Company Detail
  11.1.2 HCA Hospitals Business Overview
  11.1.3 HCA Hospitals Medical Second Opinion Introduction
  11.1.4 HCA Hospitals Revenue in Medical Second Opinion Business (2017-2022)
  11.1.5 HCA Hospitals Recent Development
11.2 AXA PPP Healthcare
  11.2.1 AXA PPP Healthcare Company Detail
  11.2.2 AXA PPP Healthcare Business Overview
  11.2.3 AXA PPP Healthcare Medical Second Opinion Introduction
  11.2.4 AXA PPP Healthcare Revenue in Medical Second Opinion Business (2017-2022)
  11.2.5 AXA PPP Healthcare Recent Development
11.3 Royal London Group
  11.3.1 Royal London Group Company Detail
  11.3.2 Royal London Group Business Overview
  11.3.3 Royal London Group Medical Second Opinion Introduction
  11.3.4 Royal London Group Revenue in Medical Second Opinion Business (2017-2022)
  11.3.5 Royal London Group Recent Development
11.4 Helsana Group
  11.4.1 Helsana Group Company Detail
  11.4.2 Helsana Group Business Overview
  11.4.3 Helsana Group Medical Second Opinion Introduction
  11.4.4 Helsana Group Revenue in Medical Second Opinion Business (2017-2022)
  11.4.5 Helsana Group Recent Development
11.5 Cleveland Clinic
  11.5.1 Cleveland Clinic Company Detail
  11.5.2 Cleveland Clinic Business Overview
  11.5.3 Cleveland Clinic Medical Second Opinion Introduction
  11.5.4 Cleveland Clinic Revenue in Medical Second Opinion Business (2017-2022)
  11.5.5 Cleveland Clinic Recent Development
11.6 Amradnet
  11.6.1 Amradnet Company Detail
  11.6.2 Amradnet Business Overview
  11.6.3 Amradnet Medical Second Opinion Introduction
  11.6.4 Amradnet Revenue in Medical Second Opinion Business (2017-2022)
  11.6.5 Amradnet Recent Development
11.7 Best Doctors Inc
  11.7.1 Best Doctors Inc Company Detail
  11.7.2 Best Doctors Inc Business Overview
  11.7.3 Best Doctors Inc Medical Second Opinion Introduction
  11.7.4 Best Doctors Inc Revenue in Medical Second Opinion Business (2017-2022)
  11.7.5 Best Doctors Inc Recent Development
11.8 Inova Care
  11.8.1 Inova Care Company Detail
  11.8.2 Inova Care Business Overview
  11.8.3 Inova Care Medical Second Opinion Introduction
  11.8.4 Inova Care Revenue in Medical Second Opinion Business (2017-2022)
  11.8.5 Inova Care Recent Development
11.9 Toranomon Hospital
  11.9.1 Toranomon Hospital Company Detail
  11.9.2 Toranomon Hospital Business Overview
  11.9.3 Toranomon Hospital Medical Second Opinion Introduction
  11.9.4 Toranomon Hospital Revenue in Medical Second Opinion Business (2017-2022)
  11.9.5 Toranomon Hospital Recent Development
11.10 Keio University Hospital
  11.10.1 Keio University Hospital Company Detail
  11.10.2 Keio University Hospital Business Overview
  11.10.3 Keio University Hospital Medical Second Opinion Introduction
  11.10.4 Keio University Hospital Revenue in Medical Second Opinion Business (2017-2022)
  11.10.5 Keio University Hospital Recent Development
11.11 Johns Hopkins Medicine
  11.11.1 Johns Hopkins Medicine Company Detail
  11.11.2 Johns Hopkins Medicine Business Overview
  11.11.3 Johns Hopkins Medicine Medical Second Opinion Introduction
  11.11.4 Johns Hopkins Medicine Revenue in Medical Second Opinion Business (2017-2022)
  11.11.5 Johns Hopkins Medicine Recent Development
11.12 Penn Medicine
  11.12.1 Penn Medicine Company Detail
  11.12.2 Penn Medicine Business Overview
  11.12.3 Penn Medicine Medical Second Opinion Introduction
  11.12.4 Penn Medicine Revenue in Medical Second Opinion Business (2017-2022)
  11.12.5 Penn Medicine Recent Development
11.13 Oncology International Pvt. Ltd.
  11.13.1 Oncology International Pvt. Ltd. Company Detail
  11.13.2 Oncology International Pvt. Ltd. Business Overview
  11.13.3 Oncology International Pvt. Ltd. Medical Second Opinion Introduction
  11.13.4 Oncology International Pvt. Ltd. Revenue in Medical Second Opinion Business (2017-2022)
  11.13.5 Oncology International Pvt. Ltd. Recent Development
11.14 GrandOpinion
  11.14.1 GrandOpinion Company Detail
  11.14.2 GrandOpinion Business Overview
  11.14.3 GrandOpinion Medical Second Opinion Introduction
  11.14.4 GrandOpinion Revenue in Medical Second Opinion Business (2017-2022)
  11.14.5 GrandOpinion Recent Development
11.15 London Pain Clinic
  11.15.1 London Pain Clinic Company Detail
  11.15.2 London Pain Clinic Business Overview
  11.15.3 London Pain Clinic Medical Second Opinion Introduction
  11.15.4 London Pain Clinic Revenue in Medical Second Opinion Business (2017-2022)
  11.15.5 London Pain Clinic Recent Development
11.16 Mondial Assistance
  11.16.1 Mondial Assistance Company Detail
  11.16.2 Mondial Assistance Business Overview
  11.16.3 Mondial Assistance Medical Second Opinion Introduction
  11.16.4 Mondial Assistance Revenue in Medical Second Opinion Business (2017-2022)
  11.16.5 Mondial Assistance Recent Development
11.17 Medisense
  11.17.1 Medisense Company Detail
  11.17.2 Medisense Business Overview
  11.17.3 Medisense Medical Second Opinion Introduction
  11.17.4 Medisense Revenue in Medical Second Opinion Business (2017-2022)
  11.17.5 Medisense Recent Development
11.18 Medo Asia Sdn. Bhd.
  11.18.1 Medo Asia Sdn. Bhd. Company Detail
  11.18.2 Medo Asia Sdn. Bhd. Business Overview
  11.18.3 Medo Asia Sdn. Bhd. Medical Second Opinion Introduction
  11.18.4 Medo Asia Sdn. Bhd. Revenue in Medical Second Opinion Business (2017-2022)
  11.18.5 Medo Asia Sdn. Bhd. Recent Development

13 REPORT CONCLUSION

14 DISCLAIMER